Ladenburg Thalmann Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $336
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsInitiationPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Ladenburg Thalmann analyst Jeffrey Cohen initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $336.
Ladenburg Thalmann analyst Jeffrey Cohen initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $336.
